Literature DB >> 21584729

X inactivation testing for identifying a non-syndromic X-linked mental retardation gene.

Hagith Yonath1, Dina Marek-Yagel, Haike Resnik-Wolf, Almogit Abu-Horvitz, Hagit N Baris, Mordechai Shohat, Moshe Frydman, Elon Pras.   

Abstract

The purpose of this study was to identify a gene causing non-syndromic X-linked mental retardation in an extended family, taking advantage of the X chromosome inactivation status of the females in order to determine their carrier state. X inactivation in the females was determined with the androgen receptor methylation assay; thereafter, the X chromosome was screened with evenly spaced polymorphic markers. Once initial linkage was identified, the region of interest was saturated with additional markers and the males were added to the analysis. Candidate genes were sequenced. Ten females showed skewed inactivation, while six revealed a normal inactivation pattern. A maximal lod score of 5.54 at θ = 0.00 was obtained with the marker DXS10151. Recombination events mapped the disease gene to a 17.4-Mb interval between the markers DXS10153 and DXS10157. Three candidate genes in the region were sequenced and a previously described missense mutation (P375L) was identified in the ACSL4/FACL4 gene. On the basis of the female X inactivation status, we have mapped and identified the causative mutation in a gene causing non-syndromic X-linked mental retardation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21584729     DOI: 10.1007/s13353-011-0052-2

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  19 in total

1.  The dynamics of X-inactivation skewing as women age.

Authors:  C Hatakeyama; C L Anderson; C L Beever; M S Peñaherrera; C J Brown; W P Robinson
Journal:  Clin Genet       Date:  2004-10       Impact factor: 4.438

Review 2.  X-linked mental retardation: many genes for a complex disorder.

Authors:  Hans-Hilger Ropers
Journal:  Curr Opin Genet Dev       Date:  2006-05-02       Impact factor: 5.578

3.  No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.

Authors:  Véronique Bolduc; Pierre Chagnon; Sylvie Provost; Marie-Pierre Dubé; Claude Belisle; Marianne Gingras; Luigina Mollica; Lambert Busque
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

4.  1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.

Authors:  S W Knight; T J Vulliamy; N S Heiss; G Matthijs; K Devriendt; J M Connor; M D'Urso; A Poustka; P J Mason; I Dokal
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

Review 5.  Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling.

Authors:  N J Faergeman; J Knudsen
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

6.  Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation.

Authors:  Catherine L Anderson; Carolyn J Brown
Journal:  Hum Genet       Date:  2002-02-01       Impact factor: 4.132

7.  FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.

Authors:  Ilaria Meloni; Maddalena Muscettola; Martine Raynaud; Ilaria Longo; Mirella Bruttini; Marie-Pierre Moizard; Marie Gomot; Jamel Chelly; Vincent des Portes; Jean-Pierre Fryns; Hans-Hilger Ropers; Barbara Magi; Cristina Bellan; Nila Volpi; Helger G Yntema; Sarah E Lewis; Jean E Schaffer; Alessandra Renieri
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

8.  Alport syndrome and mental retardation: clinical and genetic dissection of the contiguous gene deletion syndrome in Xq22.3 (ATS-MR).

Authors:  I Meloni; F Vitelli; L Pucci; R B Lowry; R Tonlorenzi; E Rossi; M Ventura; G Rizzoni; C E Kashtan; B Pober; A Renieri
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

9.  Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome?

Authors:  J J Jonsson; A Renieri; P G Gallagher; C E Kashtan; E M Cherniske; M Bruttini; M Piccini; F Vitelli; A Ballabio; B R Pober
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

10.  A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.

Authors:  I Longo; S G M Frints; J-P Fryns; I Meloni; C Pescucci; F Ariani; M Borghgraef; M Raynaud; P Marynen; C Schwartz; A Renieri; G Froyen
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

View more
  3 in total

1.  Long-chain Acyl-CoA synthetase 4A regulates Smad activity and dorsoventral patterning in the zebrafish embryo.

Authors:  Rosa Linda Miyares; Cornelia Stein; Björn Renisch; Jennifer Lynn Anderson; Matthias Hammerschmidt; Steven Arthur Farber
Journal:  Dev Cell       Date:  2013-12-12       Impact factor: 12.270

2.  Distribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutation.

Authors:  Erik W Schluter; Michael R Hunsaker; Claudia M Greco; Rob Willemsen; Robert F Berman
Journal:  Brain Res       Date:  2012-07-11       Impact factor: 3.252

3.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.

Authors:  H Hu; S A Haas; J Chelly; H Van Esch; M Raynaud; A P M de Brouwer; S Weinert; G Froyen; S G M Frints; F Laumonnier; T Zemojtel; M I Love; H Richard; A-K Emde; M Bienek; C Jensen; M Hambrock; U Fischer; C Langnick; M Feldkamp; W Wissink-Lindhout; N Lebrun; L Castelnau; J Rucci; R Montjean; O Dorseuil; P Billuart; T Stuhlmann; M Shaw; M A Corbett; A Gardner; S Willis-Owen; C Tan; K L Friend; S Belet; K E P van Roozendaal; M Jimenez-Pocquet; M-P Moizard; N Ronce; R Sun; S O'Keeffe; R Chenna; A van Bömmel; J Göke; A Hackett; M Field; L Christie; J Boyle; E Haan; J Nelson; G Turner; G Baynam; G Gillessen-Kaesbach; U Müller; D Steinberger; B Budny; M Badura-Stronka; A Latos-Bieleńska; L B Ousager; P Wieacker; G Rodríguez Criado; M-L Bondeson; G Annerén; A Dufke; M Cohen; L Van Maldergem; C Vincent-Delorme; B Echenne; B Simon-Bouy; T Kleefstra; M Willemsen; J-P Fryns; K Devriendt; R Ullmann; M Vingron; K Wrogemann; T F Wienker; A Tzschach; H van Bokhoven; J Gecz; T J Jentsch; W Chen; H-H Ropers; V M Kalscheuer
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.